Bausch + Lomb Corp BLCO

NYS: BLCO | ISIN: CA0717051076   27/06/2025
12,40 USD (+2,73%)
(+2,73%)   27/06/2025

22 december 2022 · Bausch + Lomb Amends CEO Separation Agreement · Persbericht

13 december 2022 · Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops · Persbericht

12 december 2022 · Bausch + Lomb's ONE by ONE and Biotrue® Eye Care Recycling Programs Win Gold for Most Environmentally Friendly Service of the Year from Best in Biz Awards · Persbericht

29 november 2022 · Bausch + Lomb's Biotrue® Hydration Plus Multi-Purpose Solution Receives Product of the Year Award from Business Intelligence Group's 2022 BIG Awards for Business · Persbericht

15 november 2022 · Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs · Persbericht

7 november 2022 · Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference · Persbericht

2 november 2022 · Bausch + Lomb Announces Third-Quarter 2022 Results · Persbericht

1 november 2022 · Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group · Persbericht

24 oktober 2022 · Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs · Persbericht

18 oktober 2022 · Bausch + Lomb Announces Presentation of Scientific Data and Analyses Evaluating Biotrue® Hydration Plus Multi-Purpose Solution at American Academy of Optometry Annual Meeting · Persbericht

4 oktober 2022 · Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2 · Persbericht

3 oktober 2022 · Bausch + Lomb Introduces Enhanced Ocuvite® Adult 50+ Eye Vitamin Formulation With Vitamin D · Persbericht

27 september 2022 · Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress · Persbericht

26 september 2022 · Bausch + Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting · Persbericht

21 september 2022 · Bausch + Lomb Announces Webinar for Eye Care Professionals on New AREDS2 Study Findings · Persbericht

13 september 2022 · First Annual Bausch + Lomb Sponsored Visionary Report Spotlights Nation's 'Blind Spots' on Age-related Macular Degeneration, a Leading Cause of Vision Loss for People 50+ · Persbericht

6 september 2022 · Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane) · Persbericht

1 september 2022 · Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments s.r.l. Intraocular Dyes · Persbericht

29 augustus 2022 · Bausch + Lomb Announces Participation at Upcoming Investor Conferences · Persbericht

4 augustus 2022 · Bausch + Lomb Announces Second-Quarter 2022 Results · Persbericht

Mijn selecties